This study will help clinical microbiologists estimate the impact of the withdrawal of anti-Toxoplasma IgA reference assays for the diagnosis of congenital toxoplasmosis and will contribute to actualize the recommendations for laboratory diagnosis. This evidence concerns the gene CD79A and congenital toxoplasmosis.